Effectiveness and Safety of Acupuncture for Obesity and Over-weight People
NCT ID: NCT02108236
Last Updated: 2015-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
110 participants
INTERVENTIONAL
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acupuncture in the Regulation of Dai Meridian for the Metabolism of Visceral Adipose Tissue in Abdominal Obese Patients
NCT02427347
Effect of Acupoint Thread Embedding on Obesity
NCT06316310
Acupuncture Efficacy on Lipids in Tinnitus Patients With Obesity
NCT05188365
Acupuncture for Impaired Glucose Tolerance in Overweight/Obese Population
NCT05347030
Thread Embedding Acupuncture Therapy for Weight Loss
NCT06653530
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blank control group
A control group of patients is put on a waiting list for no intervention and remaining unchanged lifestyle.
No interventions assigned to this group
intervention group
An intervention group of patients is put on a waiting list for acupuncture treatment.
acupuncture
Zhong-wan (RN12), Liang-men (ST21), Shui-fen (RN9) and Qi-hai (RN6) and bilateral acupuncture points Dai-mai (GB26), Tian-shu (ST25), Zu-sanli (ST36), Feng-long(ST40) and Liang-qiu(ST34) will be applied through the skin by acupuncture for 30 minutes every time. Electro-acupuncture apparatus will be connected to both Dai-mai, Zu-sanli and Feng-long, Zhong-wan and Qi-hai for 30 minutes with interrupted waves (2/100HZ).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
acupuncture
Zhong-wan (RN12), Liang-men (ST21), Shui-fen (RN9) and Qi-hai (RN6) and bilateral acupuncture points Dai-mai (GB26), Tian-shu (ST25), Zu-sanli (ST36), Feng-long(ST40) and Liang-qiu(ST34) will be applied through the skin by acupuncture for 30 minutes every time. Electro-acupuncture apparatus will be connected to both Dai-mai, Zu-sanli and Feng-long, Zhong-wan and Qi-hai for 30 minutes with interrupted waves (2/100HZ).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age is between 18 and 45 years.
* BMI is between 24 and 50.
* The individuals voluntarily sign the informed consent form.
* The individuals live in Harbin City of China.
Exclusion Criteria
* The individuals with server cardiovascular and cerebrovascular diseases and cancer.
* Having therapy for obesity in the last three months.
* The individuals do not adhere to the treatment or are with other treatments.
* Female individuals with pregnancy, lactation and planning a pregnancy in the two months.
* Critical patients or patients combined with liver and kidney damage.
* Individuals with visual and auditory memory disorders or psychosis.
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heilongjiang University of Chinese Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wang Ling Shu
the head of institute of chinese medicine and translational science of First Affiliated Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sun Zhongren
Role: PRINCIPAL_INVESTIGATOR
First Affiliated Hospital of Heilongjiang Chinese Medicine University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Harbin, Heilongjiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Acupuncture-Obesity-2014-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.